New Funding for Rainbow 3D Bioprinting System That May Replace Animal Toxicity Tests

In the U.S. The National Institute of Health has moved a step closer to help to fund the joint venture of Rainbow Coral Corp. and Nano3D Biosciences. Nano3D has been awarded a grant for work associated with its recent proposal Novel 3D high-content/throughput assay with mobile device-based data acquisition. Continue reading “New Funding for Rainbow 3D Bioprinting System That May Replace Animal Toxicity Tests”